Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy-
CAS655244-89-6
Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy- (CAS 655244-89-6, C6H4N4O2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
![Chemical structure of Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy-](https://chemsigma.com/chemicalStructure/65/655244-89-6.png)
- CAS No.
- 655244-89-6
- Formula
- C6H4N4O2
- Mol. weight
- 164.12 g/mol
Chemical Specifications
Identifiers
| CAS number | 655244-89-6 |
|---|---|
| Product name | Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy- |
| Molecular formula | C6H4N4O2 |
| Molecular weight | 164.12 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy-?
The CAS Registry Number of Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy- is 655244-89-6.
What is the molecular formula and molecular weight of Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy-?
The molecular formula of Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy- is C6H4N4O2, and its molecular weight is 164.12 g/mol.
How can I request a quotation for Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy-?
Send an inquiry for Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy- (CAS 655244-89-6) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for Pyrido[3,2-d]-1,2,3-triazin-4(3H)-one, 3-hydroxy-
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.